Search

Search Constraints

You searched for: Author/Creator Hanley, Daniel F

Search Results

1. A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III). Issue 5 (July 2019)

2. Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Issue 6 (1st December 2019)

3. Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Issue 6 (26th November 2018)

5. Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease. (February 2019)

6. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Issue 10175 (9th March 2019)

7. Fibrinolytic for treatment of intraventricular hemorrhage: A meta-analysis and systematic review. Issue 1 (January 2018)

8. Haptoglobin is associated with increased early perihematoma edema progression in spontaneous intracranial hemorrhage. Issue 8 (October 2020)

9. Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH Trials. (18th November 2021)

10. Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH Trials. (18th November 2021)